Vascular Surgery Risk Score (VSG NSQIP)
Estimates 30-day mortality and morbidity risk for lower extremity bypass surgery. Based on Vascular Study Group NSQIP model.
Score interpretation
→ Proceed with planned bypass; standard perioperative care; antiplatelet therapy perioperatively
→ Cardiology assessment; echocardiogram if no recent; optimise comorbidities; consider endovascular alternatives; HDU post-op
→ Senior surgeon and anaesthetist involvement; ICU planning; consider endovascular-first (EVAR/PTA) to avoid open surgery; detailed consent; MDT discussion
Interpretation bands for the VSG Risk Score. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- Revised Cardiac Risk Index (RCRI / Lee Index) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Gupta Perioperative Risk for MI or Cardiac Arrest (MICA) · Perioperative Risk
- Cardiovascular Risk in Orthotopic Liver Transplantation (CAR-OLT) Score · Perioperative Risk
- Rivaroxaban (Perioperative VTE Prophylaxis) · Direct Oral Anticoagulant — VTE Prophylaxis Post-Surgery
- Protamine Sulphate · Heparin Antidote — Vascular / Cardiac Surgery
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Ephedrine Hydrochloride 0.5% Nasal Drops · Nasal decongestant — sympathomimetic (perioperative / ENT use)
- Recombinant Factor VIIa · Bypass Agent — Haemophilia with Inhibitors
- Bevacizumab (Intravitreal) · Anti-VEGF (Vascular Endothelial Growth Factor Inhibitor)
- Peripheral Arterial Disease · NICE NG19 2012 / ESVS 2017
- Carotid Artery Disease · NICE CG68 / ESVS 2018
- Varicose Veins Management · NICE CG168 2013
- Venous Leg Ulcer Management · NICE NG204 2022
- Sodium channel blocker / LAST · AAGBI Safety Guideline 2010 (LAST); TOXBASE/NPIS; ESC
- Propofol / ketamine toxicity · TOXBASE/NPIS; AAGBI; AACT/EAPCCT
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.